Trinity Biotech Receives WHO Approval for Outsourced Uni-Gold HIV Test Production

Trinity Biotech has received WHO approval for the offshored and outsourced upstream manufacturing activities of its Uni-Gold HIV rapid test. This regulatory approval enables the company to transition production from its legacy in-house operations to a more cost-effective outsourced model while maintaining product integrity and regulatory compliance. The initiative is part of Trinity Biotech's transformation plan to drive sustainable profitability.